These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8830849)

  • 21. Dopamine D1 and D2 receptor-mediated acute and long-lasting behavioral effects of glial cell line-derived neurotrophic factor administered into the striatum.
    Kobayashi S; Ogren SO; Hoffer BJ; Olson L
    Exp Neurol; 1998 Dec; 154(2):302-14. PubMed ID: 9878169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of GDNF on fetal septal forebrain transplants in oculo.
    Price ML; Hoffer BJ; Granholm AC
    Exp Neurol; 1996 Oct; 141(2):181-9. PubMed ID: 8812151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease.
    Björklund A; Rosenblad C; Winkler C; Kirik D
    Neurobiol Dis; 1997; 4(3-4):186-200. PubMed ID: 9361295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C; Kirik D; Björklund A
    Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo.
    Strömberg I; Björklund L; Johansson M; Tomac A; Collins F; Olson L; Hoffer B; Humpel C
    Exp Neurol; 1993 Dec; 124(2):401-12. PubMed ID: 7904571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glial cell line-derived neurotrophic factor-levodopa interactions and reduction of side effects in parkinsonian monkeys.
    Miyoshi Y; Zhang Z; Ovadia A; Lapchak PA; Collins F; Hilt D; Lebel C; Kryscio R; Gash DM
    Ann Neurol; 1997 Aug; 42(2):208-14. PubMed ID: 9266731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of glial cell line-derived neurotrophic factor induced intracellular activity by K-252b on dopaminergic neurons.
    Pong K; Xu RY; Beck KD; Zhang TJ; Louis JC
    J Neurochem; 1997 Sep; 69(3):986-94. PubMed ID: 9282920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of GDNF on nigrostriatal dopaminergic function in response to a two-pulse K(+) stimulation.
    Xu K; Dluzen DE
    Exp Neurol; 2000 Dec; 166(2):450-7. PubMed ID: 11085910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue.
    Yurek DM
    Exp Neurol; 1998 Oct; 153(2):195-202. PubMed ID: 9784279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
    Connor B; Kozlowski DA; Schallert T; Tillerson JL; Davidson BL; Bohn MC
    Gene Ther; 1999 Dec; 6(12):1936-51. PubMed ID: 10637445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraspinal implants of fibrin glue containing glial cell line-derived neurotrophic factor promote dorsal root regeneration into spinal cord.
    Iwakawa M; Mizoi K; Tessler A; Itoh Y
    Neurorehabil Neural Repair; 2001; 15(3):173-82. PubMed ID: 11944738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of GDNF, BDNF, and NT-3 in the aging nigrostriatal system following a neurotoxic lesion.
    Yurek DM; Fletcher-Turner A
    Brain Res; 2001 Feb; 891(1-2):228-35. PubMed ID: 11164827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
    Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A glial cell line-derived neurotrophic factor (GDNF):tetanus toxin fragment C protein conjugate improves delivery of GDNF to spinal cord motor neurons in mice.
    Larsen KE; Benn SC; Ay I; Chian RJ; Celia SA; Remington MP; Bejarano M; Liu M; Ross J; Carmillo P; Sah D; Phillips KA; Sulzer D; Pepinsky RB; Fishman PS; Brown RH; Francis JW
    Brain Res; 2006 Nov; 1120(1):1-12. PubMed ID: 17020749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotrophin-4 (NT-4) and glial cell line-derived neurotrophic factor (GDNF) promote the survival of corticospinal motor neurons of neonatal rats in vitro.
    Junger H; Varon S
    Brain Res; 1997 Jul; 762(1-2):56-60. PubMed ID: 9262158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The neuroprotective effect of glial cell line-derived neurotrophic factor in fibrin glue against chronic focal cerebral ischemia in conscious rats.
    Cheng H; Huang SS; Lin SM; Lin MJ; Chu YC; Chih CL; Tsai MJ; Lin HC; Huang WC; Tsai SK
    Brain Res; 2005 Feb; 1033(1):28-33. PubMed ID: 15680336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo.
    Kearns CM; Gash DM
    Brain Res; 1995 Feb; 672(1-2):104-11. PubMed ID: 7749731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glial cell line-derived neurotrophic factor: distribution and pharmacology in the rat following a bolus intraventricular injection.
    Lapchak PA; Jiao S; Collins F; Miller PJ
    Brain Res; 1997 Jan; 747(1):92-102. PubMed ID: 9042532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GDNF protects against 6-OHDA nigrostriatal lesion: in vivo study with microdialysis and PET.
    Opacka-Juffry J; Ashworth S; Hume SP; Martin D; Brooks DJ; Blunt SB
    Neuroreport; 1995 Dec; 7(1):348-52. PubMed ID: 8742486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Augmented methamphetamine-induced overflow of striatal dopamine 1 day after GDNF administration.
    Cass WA; Walker DJ; Manning MW
    Brain Res; 1999 May; 827(1-2):104-12. PubMed ID: 10320698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.